Literature DB >> 11205415

What is a "low dose" of d-amphetamine for inducing behavioral effects in laboratory rats?

D M Grilly1, A Loveland.   

Abstract

BACKGROUND: Because of the amphetamines' abuse potential and capability of exacerbating or inducing mood and psychotic disturbances, investigations of the behavioral effects of amphetamines commonly involve non-human animals, with the laboratory rat being by far the most common species used. Although investigators of the behavioral effects of amphetamine in rats sometimes refer to doses used as being "low", "moderate", "high", etc., it is not clear in what sense these terms apply.
OBJECTIVES: To develop an operational definition of a low dose of amphetamine in rats, we reviewed studies that assessed the behavioral effects of dextroamphetamine (d-AMP) in rats in which some subset of doses, administered SC, IM or IP, was described as being "low". We then used the results of these studies to establish what the lowest effective dose ranges were across a variety of behavioral domains and compared these doses and their effects with those obtained with normal, healthy adult humans.
RESULTS: While the range of the lowest doses used in the studies with rats was quite broad (0.025-2.0 mg/kg), the median lowest effective doses observed (in the studies using doses of 0.125 mg/kg or less) were between 0.125 and 0.165 mg/kg across the behavioral domains of consummatory behavior, unconditioned or spontaneous behavior, learned behavior, and drug discriminative control. This range of doses was also found to be comparable to the lowest behaviorally effective doses of d-AMP (SC or PO) in normal human adults, which suggests that the sensitivity to the behavioral effects of amphetamine in these two species is fairly comparable.
CONCLUSIONS: Because of their ability to alter a wide variety of behaviors in rats, we conclude that low doses of d-AMP are in the 0.1-0.4 mg/kg range. Doses within this range typically: 1) constitute the ED50 in most drug discrimination/generalization procedures; 2) increase a variety of consummatory behaviors; 3) increase a variety of unconditioned or spontaneous motor activities; 4) increase low rate schedule-controlled behavior while exerting variable effects on high rate schedule controlled behavior; and 5) improve performance on some choice tasks, particularly those requiring sustained attention. Our analyses also indicate that, with respect to behavior, investigators do not always agree on what constitutes a low dose of amphetamine in rats and that doses assumed to be low for this species often are relatively high.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11205415     DOI: 10.1007/s002130000580

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  29 in total

1.  A genetic animal model of differential sensitivity to methamphetamine reinforcement.

Authors:  Shkelzen Shabani; Lauren K Dobbs; Matthew M Ford; Gregory P Mark; Deborah A Finn; Tamara J Phillips
Journal:  Neuropharmacology       Date:  2012-01-20       Impact factor: 5.250

2.  Acute amphetamine exposure selectively desensitizes kappa-opioid receptors in the nucleus accumbens.

Authors:  Yan-fang Xia; Li He; Jennifer L Whistler; Gregory O Hjelmstad
Journal:  Neuropsychopharmacology       Date:  2007-06-06       Impact factor: 7.853

3.  Diet-induced obesity and diet-resistant rats: differences in the rewarding and anorectic effects of D-amphetamine.

Authors:  Marta Valenza; Luca Steardo; Pietro Cottone; Valentina Sabino
Journal:  Psychopharmacology (Berl)       Date:  2015-06-07       Impact factor: 4.530

4.  Mechanisms and performance measures in mastery-based incremental repeated acquisition: behavioral and pharmacological analyses.

Authors:  Jordan M Bailey; Joshua E Johnson; M Christopher Newland
Journal:  Psychopharmacology (Berl)       Date:  2010-03-09       Impact factor: 4.530

5.  Amphetamine Exerts Dose-Dependent Changes in Prefrontal Cortex Attractor Dynamics during Working Memory.

Authors:  Christopher C Lapish; Emili Balaguer-Ballester; Jeremy K Seamans; Anthony G Phillips; Daniel Durstewitz
Journal:  J Neurosci       Date:  2015-07-15       Impact factor: 6.167

6.  Identification of multiple call categories within the rich repertoire of adult rat 50-kHz ultrasonic vocalizations: effects of amphetamine and social context.

Authors:  Jennifer M Wright; Jim C Gourdon; Paul B S Clarke
Journal:  Psychopharmacology (Berl)       Date:  2010-05-06       Impact factor: 4.530

7.  The effects of clinically relevant doses of amphetamine and methylphenidate on signal detection and DRL in rats.

Authors:  Matthew E Andrzejewski; Robert C Spencer; Rachel L Harris; Elizabeth C Feit; Brenda L McKee; Craig W Berridge
Journal:  Neuropharmacology       Date:  2014-01-24       Impact factor: 5.250

8.  Improvement of attention with amphetamine in low- and high-performing rats.

Authors:  Karly M Turner; Thomas H J Burne
Journal:  Psychopharmacology (Berl)       Date:  2016-07-28       Impact factor: 4.530

9.  The d-amphetamine-treated Göttingen miniature pig: an animal model for assessing behavioral effects of antipsychotics.

Authors:  F Josef van der Staay; Bruno Pouzet; Michel Mahieu; Rebecca E Nordquist; Teun Schuurman
Journal:  Psychopharmacology (Berl)       Date:  2009-07-23       Impact factor: 4.530

Review 10.  The effects of amphetamine on recovery of function in animal models of cerebral injury: a critical appraisal.

Authors:  Scott Barbay; Randolph J Nudo
Journal:  NeuroRehabilitation       Date:  2009       Impact factor: 2.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.